the numbers in individual groups were too small to allow a multivariate analysis. Unfortunately, six serum samples that were repeatedly positive in the enzyme immunoassay could not be tested by the recombinant immunoblot assay. However, even on the most cautious assumption-that the sample from the one heterosexual subject would have been confirmable by the recombinant immunoblot assay, and that the samples from the five homosexual subjects would not have been confirmable-the association of homosexuality with confirmed positivity for C100 antibody would remain significant (p<OO5).
If the antibody reactivity represents a specific antibody response to prior infection with hepatitis C virus then it seems that most patients whose serum samples contained C 100 antibody and were available for testing with the 5' non-coding region primers contained virus. The detection of virus in most serum samples from the homosexual men studied in which antibody was detected may imply that hepatitis C virus is maintained within this group largely by transmissions from chronically infected people. The failure in some cases of the primers based on coding regions to detect this virus is further confirmation of the genetic variability of the virus. It is important that further studies of patterns ofviraemia should take this into account when sequence targets for amplification are being chosen. With the use of the non-coding primers, the prevalence of viraemia in our patients compares with that observed in haemophiliac patients: those whose serum contains CIOO antibody are commonly viraemic (unpublished data). There are few data at present to indicate different outcomes of hepatitis C virus infection depending upon the viral dose or route of transmission, or both.
We have shown an unequivocal association between C100 antibody and male homosexuality in patients attending a genitourinary medicine clinic. The biology of hepatitis C virus infection in this group of patients does not differ from that seen in post-transfusion hepatitis and in haemophiliac patients. Results-20 of the 29 cases (69%) and 54 of the 116 controls (47%) were positive for H pylon specific antibody. The median specific IgG concentration was significantly higher in the cases than controls (90 Fg/ml v 3-6 [tg/ml, p<0-01). The estimated odds ratio for the risk of gastric cancer in those with a history of infection with H pylon was 2-77 (95% confidence interval 1-04 to 7 97, 2p=0 039).
Introduction
The bacterium Helicobacterpylon is a causative agent in the development of chronic antral gastritis.' Because gastritis, when it becomes atrophic, is a condition that predisposes to precancerous changes in the stomach2 H pylon infection is also proposed to be involved in the development of gastric cancer.3 The high prevalence of H pylori infection at an early age in population groups at high risk of gastric cancer46 supports such a hypothesis. In a recent geographical correlation study in China mortality from gastric cancer showed a significant correlation of 40% with the prevalence of antibody to H pylon.7 Clinical studies based on histopathological examination of gastric biopsy specimens showed that H pylon infection is more common in patients with gastric cancer than patients with no pathological lesions."8iO
We report findings of two prospective studies in which over 22 000 middle aged men in England and Wales gave blood samples that were subsequently stored and who were followed up for the development of cancer. We compared the prevalence of H pylon' antibodies in blood samples from those men who subsequently developed gastric cancer with that in samples from a matched control group.
Subjects and methods
Men who developed gastric cancer were identified from the participants in two prospective cohort studies, the British United Provident Association (BUPA) study and the Caerphilly collaborative heart disease (CCHD) study. Details of these studies are available elsewhere.1 12 In brief, in the first study blood samples were obtained from 20 
Results
Samples were available from a total of 29 men with gastric cancer, 23 from the BUPA study and 6 from the CCHD study. All had died with gastric cancer reported on their death certificates. In 16 of these men cancer registration details were also available, and for them the date of the initial registration was used as the date of diagnosis. For the remaining 13 men the date of death was used as the date of diagnosis. Information about the histopathological findings and the site of the tumour within the stomach was not available.
The showed the maximum concentration. The median concentration for the cases was at the maximum -that is, 90 jg/ml whereas that for the controls, 3-6[tg/ml, was below the cut off value for positivity. A nonparametric rank test'6 showed that the cases had significantly higher antibody concentrations than the controls (p<001 tExact computation. The table also shows estimates of the odds ratio after stratifying the cases into two groups, based on the interval between obtaining a blood sample and the date of diagnosis of cancer. For those men with cancer diagnosed fewer than five years after sampling the odds ratio was 2-68 whereas for those with cancer diagnosed 5-14 years after sampling the odds ratio was 2-82. The results were also similar for the 23 cases from the BUPA study and the six cases from the CCHD study.
Discussion
We showed a significant association between infection with H pylon, as determined by the presence of raised concentrations of IgG antibodies to the organism, and the risk of gastric cancer. The small number of cases, however, means that the magnitude of the odds ratio is uncertain. Nevertheless, the association we observed is unlikely to be due to chance and supports other evidence suggesting a causal association based on ecological studies,' clinical observations,8-'0 and what is known about the role ofH pylon in causing chronic gastritis.' One other casecontrol study, reported in preliminary form and using serum samples collected after diagnosis, also showed a significantly increased odds ratio of similar magnitude (3-2) in comparison with a volunteer group."
The lack of detailed clinical or histopathological information precluded analysis by site of tumour within the stomach or by histopathological tumour subtype. As the epidemiology of gastric cancer is affected by both site (cardia versus distal)'8 and histological characteristics (intestinal versus diffuse)'9 H pylori infection may have shown a more specific association with one or other of these categories.
Social class may be a potential confounding factor or an explanatory variable in studies of H pyloni infection and gastric cancer as the prevalence of both infection" and cancer'9 is increased in populations with poor socioeconomic conditions. Most of these data are from the BUPA study, which was based on a socially and economically homogeneous group of men in professional and managerial occupations. Subjects in the CCHD study were mainly in skilled and semiskilled manual occupations. As the controls were selected from the same study cohort this effectively matches for social class and indicates that our results are unlikely to be due to confounding. That there was a difference between the two cohorts, which may relate to social class, was shown by the prevalence of subjects with H pylori antibodies among the controls: 40% in the BUPA study and 71% in the CCHD study. The respective estimates for the odds ratios based on the matched analysis (2-86 and 2 25) were, however, similar. The difference in H pylori infection rates among groups of different social class may offer an explanation for the well established social class differences in risk ofgastric cancer"9 rather than being a confounding factor. Barker et al have recently showed that in England and Wales overcrowding in childhood was associated with an increased risk of gastric cancer in adult life.2' They suggested that overcrowding may predispose to transmission of H pylori in childhood and that this, in turn, might be a cause of the social class difference in the risk of cancer.
The prospective design of this study, with blood samples being collected before the diagnosis of cancer, reduces the possibility that the disease itself affected the chance of being infected by H pylori or affected the concentration of specific antibody. The exclusion of data relating to cases in which cancer was diagnosed within five years after blood sampling did not materially affect the estimate of the odds ratio, suggesting that occult disease did not have such an effect either.
The use ofan antibody test to identify prior infection may be more appropriate for this study than alternative direct methods, such as identifying H pylon in cultures or histopathological examination of gastric biopsy specimens. Severe atrophy of the stomach and the formation of foci of intestinal metaplasia, both of which probably precede the development of gastric tumours, result in reduced colonisation by H pylor.2223
In these circumstances a biopsy specimen may be negative whiles for several years the IgG antibody concentration, although falling, would remain positive, correctly indicating evidence for a past infection that is no longer active.
If our estimated odds ratio of 2 77 is correct then, because of the relatively high prevalence of H pylon infection in the general population, the estimate of attributable risk will also be high. Other studies showed that the prevalence of H pylon infection in the population in developed countries varies between 30% and 70%. 24 BMJ VOLUME 302
Introduction
Since the 1940s mortality from gastric cancer has been falling throughout the world. This has been particularly pronounced in countries such as Finland and the United States, where, by the 1980s, the annual age adjusted mortality had fallen by 73% and 66% respectively compared with 30 years earlier. ' The incidence of gastric cancer has also been reported to be falling.24 These statistics have led to gastric cancer being viewed as a disease in decline. However, the numbers of patients in our practice with gastric cancer do not seem to be declining. 6 We examined the surgical workload associated with gastric cancer in our area, the trends in the incidence of and mortality from gastric cancer in Scotland, and the implications of these data for health care provision.
Methods
In Lothian Health Board details of all general operations have been recorded since 1977 in the Lothian surgical audit scheme.7 For each procedure the surgeon codes the organ concerned, the disease process, and the nature of the operation. We examined data for 1979-88 on gastric cancer to determine the number of operations each year.
We abstracted data on the incidence of gastric cancer during 1978-87 from Scottish national cancer registration scheme records, which are held by the information and statistics division of the Scottish Health Services Common Services Agency. Population based regional registries in Edinburgh, Glasgow, Dundee, Aberdeen, and Inverness contribute data to BMJ VOLUME 302 1 JUNE 1991
